HMG-CoA-reductase-inhibitorsImmune-mediated necrotising myopathy : 25 case reports

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2018卷 / 1期
关键词：
D O I：
10.1007/s40278-024-63684-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 225
相关论文
共 50 条
  • [31] AtorvastatinImmune mediated necrotising myopathy: case report
    Reactions Weekly, 2025, 2052 (1) : 72 - 72
  • [32] LovastatinImmune mediated necrotising myopathy: case report
    Reactions Weekly, 2017, 1658 (1) : 283 - 283
  • [33] AtorvastatinImmune mediated necrotising myopathy: case report
    Reactions Weekly, 2020, 1793 (1) : 76 - 76
  • [34] AdalimumabImmune mediated necrotising myopathy: case report
    Reactions Weekly, 2021, 1881 (1) : 17 - 17
  • [35] Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab?
    Mammen, Andrew L.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (06) : 550 - 551
  • [36] MITOCHONDRIAL MYOPATHY DEVELOPING ON TREATMENT WITH THE HMG COA REDUCTASE INHIBITORS - SIMVASTATIN AND PRAVASTATIN
    ENGLAND, JDF
    WALSH, JC
    STEWART, P
    BOYD, I
    ROHAN, A
    HALMAGYI, GM
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (04): : 374 - 375
  • [37] Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases
    Marti, J.
    Kolev, I.
    Lorleac'h, A.
    Besnard, S.
    Pihan, M.
    Marcorelles, P.
    REVUE DE MEDECINE INTERNE, 2017, 38 (04): : 228 - 234
  • [38] HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions
    Huynh, T
    Cordato, D
    Yang, F
    Choy, T
    Johnstone, K
    Bagnall, F
    Hitchens, N
    Dunn, R
    INTERNAL MEDICINE JOURNAL, 2002, 32 (9-10) : 486 - 490
  • [39] HMG-CoA reductase inhibitorsMyalgia: case report
    Reactions Weekly, 2010, 1314 (1) : 22 - 22
  • [40] Treatment and outcomes in anti-HMG-CoA reductase-associated immune-mediated necrotising myopathy. Comparative analysis of a single-centre cohort and published data
    Rademacher, J-G
    Glaubitz, S.
    Zechel, S.
    Oettler, M.
    Tampe, B.
    Schmidt, J.
    Korsten, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (02) : 320 - 328
12345